TD Asset Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.43M | Sell |
|
|||||
|
2025
Q1 | $8.22M | Sell |
|
|||||
|
2024
Q4 | $6.7M | Buy |
|
|||||
|
2024
Q3 | $7.67M | Buy |
|
|||||
|
2024
Q2 | $5.14M | Buy |
|
|||||
|
2024
Q1 | $3.14M | Sell |
|
|||||
|
2023
Q4 | $2.54M | Hold |
|
|||||
|
2023
Q3 | $1.85M | Buy |
|
|||||
|
2023
Q2 | $1.53M | Buy |
|
|||||
|
2023
Q1 | $667K | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $422K | Sell |
|
|||||
|
2021
Q4 | $1.13M | Sell |
|
|||||
|
2021
Q3 | $834K | Sell |
|
|||||
|
2021
Q2 | $3.4M | Buy |
|
|||||
|
2021
Q1 | $1.59M | Buy |
|
|||||
|
2020
Q4 | $1.03M | Buy |
|
|||||
|
2020
Q3 | $769K | Hold |
|
|||||
|
2020
Q2 | $695K | Buy |
|